Nasdaq - Delayed Quote USD
Rydex Mid-Cap 1.5x Strategy A (RYAHX)
As of 8:06:11 a.m. EST. Market Open.
Fund Summary
The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in securities of companies included in the underlying index and derivatives and other instruments whose performance is expected to correspond to that of the underlying index. The index is a modified capitalization-weighted index composed of 400 mid-cap stocks chosen by S&P for market size, liquidity, and industry group representation. The fund is non-diversified.
Rydex Mid-Cap 1.5x Strategy A
Rockville, MD 20850
9601 Blackwell Road,Suite 500
Fund Overview
Category | Trading--Leveraged Equity |
Fund Family | Rydex Funds |
Net Assets | 14.96M |
YTD Return | 15.47% |
Yield | 0.72% |
Morningstar Rating | |
Inception Date | Aug 16, 2001 |
Fund Operations
Last Dividend | 0.95 |
Last Cap Gain | 14.00 |
Holdings Turnover | 57.00% |
Average for Category | -- |
Fees & Expenses
Expense | RYAHX | Category Average |
---|---|---|
Annual Report Expense Ratio (net) | 1.71% | 0.00% |
Prospectus Net Expense Ratio | 1.71% | -- |
Prospectus Gross Expense Ratio | 1.81% | -- |
Max 12b1 Fee | -- | -- |
Max Front End Sales Load | -- | -- |
Max Deferred Sales Load | -- | -- |
3 Yr Expense Projection | 0 | -- |
5 Yr Expense Projection | 0 | -- |
10 Yr Expense Projection | 0 | -- |
Management Information
Michael P. Byrum, Lead Manager since August 16, 2001
Michael P. Byrum, CFA, Senior Vice President—Mr. Byrum has been associated with the Security Investors since 1993. Mr. Byrum was the inaugural portfolio manager for many of the Rydex products, including the Rydex leveraged and inverse funds, sector fund lineup and alternative investment portfolios. Today, Mr. Byrum continues to play an instrumental role in product development and investment strategy at Guggenheim Investments and oversees the trading, research and portfolio management activities of the quantitative strategies team, which focuses on target beta, alternative and asset allocation strategies.
He is the chairman of the Investment Strategy Committee and is a member of the Risk Management Committee and Credit Review Committee.
Prior to joining the Security Investors, Mr. Byrum served in a brokerage capacity with Money Management Associates, the registered investment advisor to Rushmore Funds, Inc.
He earned a B.S. in finance from the Miami University of Ohio. He also has earned the right to use the Chartered Financial Analyst® designation and is a member of the CFA Institute and the CFA Society of Washington. Morningstar Style Box
Morningstar Category
Related Tickers
BIPIX ProFunds Biotechnology UltraSector Fund
45.80
+4.30%
BIPSX ProFunds Biotechnology UltraSector Fund
23.89
+4.28%
UMPIX ProFunds UltraMid Cap Fund
73.98
+3.22%
UMPSX ProFunds UltraMid Cap Fund
57.08
+3.22%
UPAAX Upright Assets Allocation Plus
15.22
+3.05%
UPDDX Upright Growth & Income
21.06
+2.93%
BDFIX Baron Discovery Fund
35.09
+2.84%
BDFFX Baron Discovery Fund
34.07
+2.84%
QSMRX AQR Small Cap Momentum Style R6
20.04
+2.61%
ASMOX AQR Small Cap Momentum Style I
20.17
+2.59%
ASMNX AQR Small Cap Momentum Style N
20.18
+2.59%
INIIX VanEck International Investors Gold I
16.24
+2.59%
HFCGX Hennessy Cornerstone Growth Investor
34.09
+2.59%
HICGX Hennessy Cornerstone Growth Inst
35.62
+2.56%
RYCYX Rydex Dow 2x Strategy C
148.12
+2.51%
WCMSX WCM International Small Cap Growth Instl
21.25
+2.51%
RYLDX Rydex Dow 2x Strategy A
179.48
+2.51%
RYCVX Rydex Dow 2x Strategy H
178.71
+2.51%
PRHSX T. Rowe Price Health Sciences
82.73
+2.50%
MSSGX Morgan Stanley Inst Inception I
16.80
+2.50%
THISX T. Rowe Price Health Sciences I
82.93
+2.50%
MFLLX Morgan Stanley Inst Inception R6
16.99
+2.47%
RYMDX Rydex Mid-Cap 1.5x Strategy H
142.93
+2.44%
UDPIX ProFunds Ultra Dow 30 ProFund
84.27
+2.43%
APHDX Artisan Global Discovery Fund
22.46
+2.42%
FNORX Fidelity Nordic
58.50
+2.42%
APFDX Artisan Global Discovery Fund
22.16
+2.40%
APDDX Artisan Global Discovery Fund
22.26
+2.39%
QISGX Federated Hermes MDT Small Cap Growth IS
29.29
+2.38%
QASGX Federated Hermes MDT Small Cap Growth A
27.14
+2.38%
FSMEX Fidelity Select Medical Tech and Devcs
66.96
+2.34%
FGRSX Federated Hermes Intl Leaders R6
36.58
+2.32%
LCMGX Lord Abbett Micro Cap Growth Fund
21.22
+2.31%
LMIYX Lord Abbett Micro Cap Growth I
22.18
+2.31%
LFMGX Lord Abbett Micro Cap Growth F
22.18
+2.31%
SSYGX BNY Mellon Small Cap Gr Y
43.48
+2.31%
FGFLX Federated Hermes Intl Leaders IS
36.63
+2.29%
SSETX BNY Mellon Small Cap Gr I
43.34
+2.29%
PHLQX PGIM Jennison Health Sciences R6
44.75
+2.29%
FTXAX FullerThaler Behavioral Sm-Cp Gr A
50.58
+2.29%
LAMGX Lord Abbett Micro Cap Growth A
17.91
+2.28%
PHLAX PGIM Jennison Health Sciences A
34.57
+2.28%
PJHRX PGIM Jennison Health Sciences R
31.88
+2.28%
FTXCX FullerThaler Behavioral Sm-Cp Gr C
48.96
+2.28%
BUFIX Buffalo International
21.58
+2.27%
FTXFX FullerThaler Behavioral Sm-Cp Gr R6
52.16
+2.27%
BUIIX Buffalo International Institutional
21.59
+2.27%
MNOWX Manning & Napier Overseas Series W
33.76
+2.27%
FSPHX Fidelity Select Health Care
28.38
+2.27%
PHSZX PGIM Jennison Health Sciences Z
44.30
+2.26%
FTXNX FullerThaler Behavioral Sm-Cp Gr Inv
50.74
+2.26%
FTXSX FullerThaler Behavioral Sm-Cp GrInstl
51.80
+2.25%
MNOZX Manning & Napier Overseas Series Z
33.66
+2.25%
MNOSX Manning & Napier Overseas Series S
33.69
+2.25%
NEAGX Needham Aggressive Growth Retail
49.71
+2.24%
NEAIX Needham Aggressive Growth Institutional
52.50
+2.24%
BHCHX Baron Health Care Fund
20.12
+2.24%
BSFIX Baron Small Cap Instl
35.29
+2.23%
TAVZX Third Avenue Value Z
59.70
+2.23%
TAVFX Third Avenue Value Instl
59.74
+2.22%
PVIVX Paradigm Micro-Cap
59.77
+2.22%
TVFVX Third Avenue Value Investor
60.26
+2.22%
BSCFX Baron Small Cap Retail
32.24
+2.22%
BHCFX Baron Health Care Fund
19.83
+2.22%
WGROX Wasatch Core Growth
95.77
+2.21%
WIGRX Wasatch Core Growth Institutional
97.89
+2.20%
BSCUX Baron Small Cap R6
35.27
+2.20%
BHCUX Baron Health Care Fund
20.11
+2.18%
FBTTX Fidelity Advisor Biotechnology Fund
24.24
+2.15%
LSSNX Loomis Sayles Small Cap Growth N
31.40
+2.15%
FBTAX Fidelity Advisor Biotechnology Fund
26.65
+2.15%
ISCIX Federated Hermes Intl Small-Mid Co IS
41.07
+2.14%
BUISX Buffalo Small Cap Growth Institutional
15.78
+2.14%
FMPFX Nuveen Small Cap Growth Opp R6
38.45
+2.02%
ISCAX Federated Hermes Intl Small-Mid Co A
39.78
+2.13%
FBTIX Fidelity Advisor Biotechnology Fund
29.27
+2.13%
ISCCX Federated Hermes Intl Small-Mid Co C
26.88
+2.13%
FIJYX Fidelity Advisor Biotechnology Z
29.32
+2.12%
BRUSX Bridgeway Ultra-Small Company
33.81
+2.11%
TARKX Tarkio
30.63
+2.10%
GSXIX abrdn US Small Cap Equity Inst Svc
43.32
+2.10%
FIIIX Fidelity Advisor International Growth I
21.01
+2.09%
BCSVX Brown Capital Management International Small Company Fund
24.93
+2.09%
FZAJX Fidelity Advisor International Growth Z
21.02
+2.09%
NWKCX Nationwide Geneva Small Cap Gr R6
92.41
+2.09%
NWKDX Nationwide Geneva Small Cap Gr Instl Svc
91.00
+2.09%
NWHZX Nationwide Geneva Small Cap Gr A
86.16
+2.09%
FSHCX Fidelity Select Health Care Svcs Port
107.22
+2.09%
GSCIX abrdn US Small Cap Equity Inst
43.60
+2.08%
FIGFX Fidelity International Growth
21.07
+2.08%
FPHAX Fidelity Select Pharmaceuticals Port
24.99
+2.08%
BCSFX Brown Capital Management International Small Company Fund
25.52
+2.08%
VRREX Virtus Duff & Phelps Real Estate Secs R6
19.14
+2.08%
CSMCX Congress Small Cap Growth Institutional
49.13
+2.08%
FOSFX Fidelity Overseas
65.38
+2.08%
DVSMX Driehaus Small Cap Growth Investor
24.12
+2.07%
DNSMX Driehaus Small Cap Growth Institutional
24.62
+2.07%
FOSKX Fidelity Overseas K
65.00
+2.07%
FAOSX Fidelity Advisor Overseas Z
33.55
+2.07%